An IMRT/VMAT Technique for Nonsmall Cell Lung Cancer

被引:19
|
作者
Zhao, Nan [1 ]
Yang, Ruijie [1 ]
Wang, Junjie [1 ]
Zhang, Xile [1 ]
Li, Jinna [1 ]
机构
[1] Peking Univ, Hosp 3, Dept Radiat Oncol, Beijing 100191, Peoples R China
基金
中国国家自然科学基金;
关键词
MODULATED RADIATION-THERAPY; ARC THERAPY; HELICAL TOMOTHERAPY; PLAN QUALITY; IMRT; VMAT; RADIOTHERAPY; OPTIMIZATION; VOLUME; EFFICIENCY;
D O I
10.1155/2015/613060
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The study is to investigate a Hybrid IMRT/VMAT technique which combines intensity modulated radiation therapy (IMRT) and volumetric modulated arc therapy (VMAT) for the treatment of nonsmall cell lung cancer (NSCLC). Two partial arcs VMAT, 5-field IMRT, and hybrid plans were created for 15 patients with NSCLC. The hybrid plans were combination of 2 partial arcs VMAT and 5-field IMRT. The dose distribution of planning target volume (PTV) and organs at risk (OARs) for hybrid technique was compared with IMRT and VMAT. The monitor units (MUs) and treatment delivery time were also evaluated. Hybrid technique significantly improved the target conformity and homogeneity compared with IMRT and VMAT. The mean delivery time of IMRT, VMAT, and hybrid plans was 280 s, 114 s, and 327 s, respectively. The mean MUs needed for IMRT, VMAT, and hybrid plans were 933, 512, and 737, respectively. Hybrid technique reduced V-5, V-10, V-30, and MLD of normal lung compared with VMAT and spared the OARs better with fewer MUs with the cost of a little higher V-5, V-10, and mean lung dose (MLD) of normal lung compared with IMRT. Hybrid IMRT/VMAT can be a viable radiotherapy technique with better plan quality.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Targeted therapy in nonsmall cell lung cancer
    Puri, T.
    INDIAN JOURNAL OF CANCER, 2017, 54 (01) : 83 - 88
  • [32] Nonsmall cell lung cancer in never smokers
    Scagliotti, Giorgio V.
    Longo, Marina
    Novello, Silvia
    CURRENT OPINION IN ONCOLOGY, 2009, 21 (02) : 99 - 104
  • [33] Perioperative immunotherapy for nonsmall cell lung cancer
    Huang, Jingya
    Li, Wenyuan
    Guo, Hui
    CURRENT OPINION IN ONCOLOGY, 2025, 37 (01) : 63 - 72
  • [34] Chemoradiation therapy in nonsmall cell lung cancer
    Baas, Paul
    Belderbos, Jose S. A.
    van den Heuvel, Michel
    CURRENT OPINION IN ONCOLOGY, 2011, 23 (02) : 140 - 149
  • [35] Perioperative immunotherapy in nonsmall cell lung cancer
    Zhang, Renzhi
    Zou, Chun
    Zeng, Liang
    Zhang, Yongchang
    CURRENT OPINION IN ONCOLOGY, 2025, 37 (01) : 40 - 47
  • [36] A Hybrid VMAT/IMRT Technique for the Treatment of Nasopharyngeal Carcinoma
    Zhao, N.
    Yang, R.
    Wang, J.
    MEDICAL PHYSICS, 2014, 41 (06) : 225 - +
  • [37] The Impact of Density Overrides in IMRT and VMAT Planning for Lung Cancer Patients Treated SBRT
    Qin, Y.
    Chetty, I.
    MEDICAL PHYSICS, 2016, 43 (06) : 3588 - 3588
  • [38] Bronchoscopic treatment of inoperable nonsmall cell lung cancer
    Kniese, Christopher M.
    Musani, Ali, I
    EUROPEAN RESPIRATORY REVIEW, 2020, 29 (158): : 1 - 10
  • [39] Thyroid Metastasis from Nonsmall Cell Lung Cancer
    Namad, Tariq
    Wang, Jiang
    Shipley, Ralph
    Karim, Nagla Abdel
    CASE REPORTS IN ONCOLOGICAL MEDICINE, 2013, 2013
  • [40] PROGNOSTIC FACTORS IN NONSMALL CELL LUNG-CANCER
    FELD, R
    BORGES, M
    GINER, V
    GINSBERG, R
    HARPER, P
    KLASTERSKY, J
    LACQUET, L
    PAESMANS, M
    PAYNE, D
    ROSELL, R
    SAUSE, W
    SCULIER, JP
    SHAW, E
    SORENSEN, JB
    SPLINTER, T
    STAHEL, R
    BUNN, P
    LUNG CANCER, 1994, 11 : S19 - S23